The aim of this study was to establish whether the site of lymph node metastasis influences the survival of patients with carcinoma of the thoracic esophagus. Methods: A series of 159patients with lymphnodemetastasis who underwent righttransthoracic R o esophagectomy was analyzed retrospectively. Sites of the nodal metastasis were divided into two regions; the neck and/or upper mediastinum above (upward metastasis) and the abdomen and/or lower mediastinum below (downward metastasis) the tracheal carina. Results: Univariate analysis of prognostic factors revealed the tumor location, distant lymphatic metastasis, number of metastatic nodes and upward metastasis influenced survival, but downward metastasis did not. Multivariate analysis showed that the numberof metastatic nodes and upward metastasis were also significant prognostic factors. Thirty-one (33.3%) of the 93 patients with, but only 6 (9.1 0 /0) without, upward metastasis had recurrences in the neck and/or upper mediastinum (P =0.0002). Eighteen (60.0%) of the 30 patients with extranodal invasion in the neck and/or upper mediastinum had recurrence in these regions. Conclusions: Nodal metastasis in the neck and/or upper mediastinum was a significant risk factor for prognosis, the same as the number of metastatic nodes.
INTRODUCTION
During the past decade, subtotal esophagectomy with cervicothoracoabdominal three-field dissection has become an option for the surgical treatment of esophageal cancer, allowing more accurate staging and revealing the pattern of lymph node metastasis (1) (2) (3) . The recurrent nerve lymphatic chains and the abdominal paracardiac nodes are the lymph nodes most commonly affected by metastatic carcinoma of the thoracic esophagus (4) . However, according to the TNM classification (5), the recurrent nerve lymphatic chains in the neck are classified as distant lymph nodes, and those in the upper mediastinum as regional lymph nodes. During the surgery, it is difficult to differentiate the cervical nodes from the upper mediastinal nodes, especially recurrent nerve lymphatic chains. Nowadays, the number of metastatic nodes is considered to be one of the most important prognostic factors (6) (7) (8) , but whether the site of lymph node metastasis influences Received January 11, 1999; accepted March 10, 1999 For reprints and all correspondence: Shizuo Nakano, The First Department of Surgery, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-0075, Japan. E-mail: nakano@med1.kufm.kagoshima-u.ac.jp patient outcome is unclear. The aim of this study was to determine whether the site of the metastatic nodes influences the survival of patients with carcinomas of the thoracic esophagus.
PATIENTS AND METHODS
From 1983 to 1996,275 patients with carcinomas of the thoracic esophagus underwent Ro (5) radical esophagectomy througha right thoracotomy and laparotomy. Lymph node metastasis was confirmed histologically in 168 (61.2%) of these 275 patients. Nine (5.3%) of these 168 patients died during primary hospitalization and were excluded from this study, but the remaining 159 with lymph node metastasis were analyzed. This group included 105 and 54 patients who underwent cervicothoracoabdominal three-field dissection and thoracoabdominal two-field dissection with a sampling of the cervical paraesophageal nodes at the time of anastomosis in the neck, respectively. Sites of the nodal metastasis were divided into two regions; the neck and/or upper mediastinum above and the abdomen and/or lower mediastinum below the tracheal carina (upward and downward metastasis, respectively). Patients with upward metastasis mainly had metastasis to the cervical nodes, recurrent nerve lymphatic chains and infra-aortic nodes and those with downward metastasis had metastasis to the subcarinal and paraesophageal nodes and nodes .. ...
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249 logistic regression analysis revealed two independent prognostic factors among the 13 variables, the number of metastatic nodes and upward metastasis (Table 2) . Lymph node metastasis involving four or more nodes and the presence of upward metastasis in the neck and/or upper mediastinum had a significant adverse effect on survival. Recurrences occurred in 91 (57.2%) of the 159 patients (Table 3 ) atone month to 61 months after surgery (average 12 months). Thirty-one (33.3%) of the 93 patients with upward metastasis had recurrences in the neck and/or upper mediastinum, whereas only 6 (9.1%) of the 66 without upward metastasis had recurrences in these regions. 
RECURRENCE AND SURVIVAL RATES IN 93 ESOPHAGEAL CANCER PATIENTS WITH UPWARD METASTASIS
The sites of recurrence in the 93 patients with upward metastasis were analyzed according to the presence of extranodal invasion in the neck and/or upper mediastinum (Table 4) . Eighteen (60.0%) of the 30 patients with extranodal invasion in the neck and/or upper mediastinum had recurrences in these regions, whereas only 13 (20.6%) of the 63 without extranodal invasion had recurrence in these regions, regardless of upward metastasis.
DISCUSSION
It is well known that nodal metastasis occurs frequently in patients with esophageal carcinomas and the extent of nodal metastasis, particularly the number of metastatic nodes, has been found to be a definitive prognostic factor (8). Skinner et al. (11) reported that the critical number of metastatic nodes was three or four and Matsubara et aI. (12) analyzed 171 patients who underwent three-field lymphadenectomy and found that the outcome was unfavorable when more than seven nodes were involved. In our study, univariate and multivariate analyses indicated that the number of metastatic nodes was one of the most significant prognostic factors, as was the site of nodal metastasis. Nodal metastasis in the neck and/or upper mediastinum (upward metastasis) was a poor prognostic factor, whereas nodal metastasis in the abdomen and/or lower mediastinum (downward metastasis) was not. In our series, recurrences were observed frequently in the neck and/or upper mediastinum in patients with upward metastasis. Skinner (13) stated that during embryonic life, the esophagus distal to the tracheal bifurcation had a mesoesophagus, which determined the direction of its vascular and lymphatic drainage, whereas the esophagus proximal to the tracheal bifurcation had no such mesoesophagus. Consequently, the lymphatic flow in the neck and/or upper mediastinum is more complicated than that in the proximal regions and this may explain why recurrences are observed so often in the neck and/or upper mediastinum, even after extended dissection. Gatzinsky et al. (14) found that 51% of patients with nodal metastasis had perinodal carcinomatous involvement (extranodal invasion). Similarly, Baba et al. (4) demonstrated that the incidence of extranodal invasion correlated with the number of metastatic nodes and that extranodal invasion occurred most frequently in the upper gastric region and in the region along the recurrent nerves. Watanabe et al. (15) reported that 16 of 18 patients with perinodal invasion died of recurrence within one year of surgery. In fact, in our series, 18 (60.0%) of the 30 patients with extranodal invasion in the neck and/or upper mediastinum had recurrences in these regions. Therefore, nodal metastasis in the neck and/or upper mediastinum accompanying extranodal invasion was deemed equivalent to systemic disease.
